PHILADELPHIA – Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab...
PHILADELPHIA – People who received information from the Screen to Save program, a culturally tailored initiative from the National...
PHILADELPHIA – A risk prediction model that combined genetic and clinical factors with circulating biomarkers identified people at significantly...
PHILADELPHIA – Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis, according to results...
PHILADELPHIA – A high-resolution, three-dimensional imaging technique, when combined with quantitative measurement of tissue elasticity, could accurately detect cancer...
PHILADELPHIA – An increased proportion of Indigenous American (IA) ancestry was associated with a greater incidence of HER2-positive breast...
Some mammographic features are associated with increased breast cancer risk PHILADELPHIA – An analysis of a large Swedish cohort...
PHILADELPHIA – A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types,...
PHILADELPHIA – Using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC), researchers utilized...
PHILADELPHIA – The protein peptidyl arginine deiminase 4 (PAD4), which enables some immune cells to trap bacteria, promoted breast...